Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score.

Onengut-Gumuscu S, Chen WM, Robertson CC, Bonnie JK, Farber E, Zhu Z, Oksenberg JR, Brant SR, Bridges SL Jr, Edberg JC, Kimberly RP, Gregersen PK, Rewers MJ, Steck AK, Black MH, Dabelea D, Pihoker C, Atkinson MA, Wagenknecht LE, Divers J, Bell RA; SEARCH for Diabetes in Youth; Type 1 Diabetes Genetics Consortium, Erlich HA, Concannon P, Rich SS.

Diabetes Care. 2019 Mar;42(3):406-415. doi: 10.2337/dc18-1727. Epub 2019 Jan 18.

PMID:
30659077
2.

Correction: High resolution HLA analysis reveals independent class I haplotypes and amino-acid motifs protective for multiple sclerosis.

Mack SJ, Udell J, Cohen F, Osoegawa K, Hawbecker SK, Noonan DA, Ladner MB, Goodridge D, Trachtenberg EA, Oksenberg JR, Erlich HA.

Genes Immun. 2019 Apr;20(4):340. doi: 10.1038/s41435-018-0037-9.

PMID:
29915315
3.
4.

Applications of Probe Capture Enrichment Next Generation Sequencing for Whole Mitochondrial Genome and 426 Nuclear SNPs for Forensically Challenging Samples.

Shih SY, Bose N, Gon├žalves ABR, Erlich HA, Calloway CD.

Genes (Basel). 2018 Jan 22;9(1). pii: E49. doi: 10.3390/genes9010049. Erratum in: Genes (Basel). 2018 Feb 14;9(2):.

5.

High resolution HLA analysis reveals independent class I haplotypes and amino-acid motifs protective for multiple sclerosis.

Mack SJ, Udell J, Cohen F, Osoegawa K, Hawbecker SK, Noonan DA, Ladner MB, Goodridge D, Trachtenberg EA, Oksenberg JR, Erlich HA.

Genes Immun. 2019 Apr;20(4):308-326. doi: 10.1038/s41435-017-0006-8. Epub 2018 Jan 8. Erratum in: Genes Immun. 2018 Jun 18;:.

6.

A phylogenetic approach for haplotype analysis of sequence data from complex mitochondrial mixtures.

Vohr SH, Gordon R, Eizenga JM, Erlich HA, Calloway CD, Green RE.

Forensic Sci Int Genet. 2017 Sep;30:93-105. doi: 10.1016/j.fsigen.2017.05.007. Epub 2017 May 29.

7.
8.

The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test.

Schiffman M, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Apple R, Aldrich C, Erlich HA, Tam T, Befano B, Burk RD, Castle PE.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1304-10. doi: 10.1158/1055-9965.EPI-14-1353. Epub 2015 Jun 18.

9.

HLA typing using next generation sequencing: An overview.

Erlich HA.

Hum Immunol. 2015 Dec;76(12):887-90. doi: 10.1016/j.humimm.2015.03.001. Epub 2015 Mar 14. Review. No abstract available.

PMID:
25777625
10.

Major association of vitiligo with HLA-A*02:01 in Japanese.

Jin Y, Hayashi M, Fain PR, Suzuki T, Fukai K, Oiso N, Tanemura A, Holcomb CL, Rastrou M, Erlich HA, Spritz RA.

Pigment Cell Melanoma Res. 2015 May;28(3):360-2. doi: 10.1111/pcmr.12356. Epub 2015 Feb 17. No abstract available.

11.

Human NK cells licensed by killer Ig receptor genes have an altered cytokine program that modifies CD4+ T cell function.

Lin L, Ma C, Wei B, Aziz N, Rajalingam R, Yusung S, Erlich HA, Trachtenberg EA, Targan SR, McGovern DP, Heath JR, Braun J.

J Immunol. 2014 Jul 15;193(2):940-9. doi: 10.4049/jimmunol.1400093. Epub 2014 Jun 16.

12.

Receiver operating characteristic analysis of HLA, CTLA4, and insulin genotypes for type 1 diabetes.

Valdes AM, Varney MD, Erlich HA, Noble JA.

Diabetes Care. 2013 Sep;36(9):2504-7. doi: 10.2337/dc12-2284. Epub 2013 Apr 29.

13.

Prediction of type 1 diabetes.

Erlich HA, Valdes AM, Noble JA.

Diabetes. 2013 Apr;62(4):1020-1. doi: 10.2337/db12-1593. No abstract available.

14.

Next generation sequencing reveals the association of DRB3*02:02 with type 1 diabetes.

Erlich HA, Valdes AM, McDevitt SL, Simen BB, Blake LA, McGowan KR, Todd JA, Rich SS, Noble JA; Type 1 Diabetes Genetics Consortium (T1DGC).

Diabetes. 2013 Jul;62(7):2618-22. doi: 10.2337/db12-1387. Epub 2013 Mar 5.

15.

A sequence-based approach demonstrates that balancing selection in classical human leukocyte antigen (HLA) loci is asymmetric.

Bronson PG, Mack SJ, Erlich HA, Slatkin M.

Hum Mol Genet. 2013 Jan 15;22(2):252-61. doi: 10.1093/hmg/dds424. Epub 2012 Oct 12.

16.

HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk.

Urayama KY, Chokkalingam AP, Metayer C, Ma X, Selvin S, Barcellos LF, Wiemels JL, Wiencke JK, Taylor M, Brennan P, Dahl GV, Moonsamy P, Erlich HA, Trachtenberg E, Buffler PA.

Blood. 2012 Oct 11;120(15):3039-47. doi: 10.1182/blood-2012-01-404723. Epub 2012 Aug 24.

17.

Evidence of gene-gene interaction and age-at-diagnosis effects in type 1 diabetes.

Howson JM, Cooper JD, Smyth DJ, Walker NM, Stevens H, She JX, Eisenbarth GS, Rewers M, Todd JA, Akolkar B, Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, Pociot F, Rich SS; Type 1 Diabetes Genetics Consortium.

Diabetes. 2012 Nov;61(11):3012-7. doi: 10.2337/db11-1694. Epub 2012 Aug 13.

18.

Next-generation DNA re-sequencing identifies common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation.

Jin Y, Ferrara T, Gowan K, Holcomb C, Rastrou M, Erlich HA, Fain PR, Spritz RA.

J Invest Dermatol. 2012 Jun;132(6):1730-3. doi: 10.1038/jid.2012.37. Epub 2012 Mar 8. No abstract available.

19.

Genetics of type 1 diabetes.

Noble JA, Erlich HA.

Cold Spring Harb Perspect Med. 2012 Jan;2(1):a007732. doi: 10.1101/cshperspect.a007732. Review.

20.

A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement.

Hollenbach JA, Mack SJ, Gourraud PA, Single RM, Maiers M, Middleton D, Thomson G, Marsh SG, Varney MD; Immunogenomics Data Analysis Working Group.

Tissue Antigens. 2011 Nov;78(5):333-44. doi: 10.1111/j.1399-0039.2011.01777.x.

Supplemental Content

Loading ...
Support Center